Field Trip Health (FTRP) Financials
$2.15
$0.07
(3.37%)
As on 18-Oct-2022 09:30EDT
Market cap
$10 Mln
Revenue (TTM)
$4 Mln
P/E Ratio
--
P/B Ratio
1.1
Div. Yield
0 %
Cashflow (CA$ Mln) |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-44.26
|
-16.41
|
-1.93
|
--
|
--
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
68.92
|
-75.07
|
-0.94
|
--
|
--
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-0.27
|
121.29
|
12.61
|
--
|
--
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash EPS (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Adjusted Book Value (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Free Cash Flow per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-50.39
|
-34.76
|
--
|
--
|
--
|
|
|
|
|
|
|
ROE (%)
|
-84.17
|
-60.59
|
-37.29
|
--
|
--
|
--
|
|
|
|
|
|
|
ROA (%)
|
-44.97
|
-47.85
|
-33.26
|
--
|
--
|
--
|
|
|
|
|
|
|
EBIT Margin (%)
|
-1,153.10
|
-1,102.74
|
-2,374.28
|
-260,576.20
|
--
|
--
|
|
|
|
|
|
|
Net Margin (%)
|
-1,392.95
|
-1,125.30
|
-2,405.84
|
-262,832.40
|
--
|
--
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
121.24
|
4.06
|
959.90
|
--
|
--
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
-42.64
|
-134.92
|
-775.53
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-70.14
|
-136.58
|
-779.56
|
--
|
--
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.43
|
0.07
|
0.15
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.03
|
0.01
|
0.04
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
2.53
|
8.20
|
17.97
|
9.62
|
--
|
--
|
|
|
|
|
|
|
Quick Ratio
|
2.53
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Interest Coverage
|
-47.98
|
-48.89
|
-75.22
|
-115.49
|
--
|
--
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
1.00
|
25.28
|
84.69
|
20,311.20
|
--
|
--
|
|
|
|
|
|
|
Asset Turnover
|
0.03
|
0.04
|
0.01
|
--
|
--
|
--
|
|
|
|
|
|
|
Receivable days
|
--
|
76.75
|
193.26
|
74,186.66
|
--
|
--
|
|
|
|
|
|
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Payable days
|
--
|
179.08
|
401.64
|
10,497.00
|
--
|
--
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
